George Magoulas
SEEK ID: https://fairdomhub.org/people/2703
Location:
Greece
ORCID:
https://orcid.org/0000-0001-8944-1635
Joined: 14th May 2025
Expertise: Organic Synthesis, small molecules, heterocycles
Tools: NMR spectroscopy, Green Chemistry, Flash Column Chromatography
Their tagsRelated items
The recent COVID19 pandemic infection has undisclosed long-standing issues in the translation of drugs from animals to humans or vice-versa. Nearly 75% of emerging human infections worldwide originated from animals; existing drugs for human and animal (H&A) vector-borne diseases (VBD) are scarce, with limited efficacy, toxicity, and finite resources. Emerging environmental problems in pharmaceutical use/manufacturing increase attention in the field. The two drug pipelines are developed ...
Projects: WG1 - Compound libraries coordination and integration of compound design, WG2 - Integration of early phase studies and low environmental impact actions, WG3 - Coordination of in vitro-to-in vivo translation of OneHealth leads and candidates, WG4 - Integration of R&D process-environmental studies and translation in informed whitepaper, WG5 - Promote dissemination, WG6 - Promote the transfer of knowledge, BioTarget Database, Compound Data
Web page: https://onehealthdrugs.com/
Public web page: Not specified
Public web page: Not specified
ROR ID: Not specified
Department: Not specified
Country: Greece
City: Athens
Web page: http://www.eie.gr/
Abstract (Expand)
Authors: Alberto Venturelli, Lorenzo Tagliazucchi, Clara Lima, Federica Venuti, Giulia Malpezzi, George E. Magoulas, Nuno Santarem, Theodora Calogeropoulou, Anabela Cordeiro-da-Silva, Maria Paola Costi
Date Published: 27th Jun 2022
Publication Type: Journal Article
